ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Irinotecan Fresenius 500 mg/25 ml, Konzentrat zur Herstellung einer Infusionslösung - 
61246020 Fresenius Kabi (Schweiz) AG
Irinotecan Fresenius 500 mg/25 ml, Konzentrat zur Herstellung einer Infusionslösung28.01.2011
Generic28.01.2011
Irinotecan (L01XX19) 
WHO-DDD 
07.16.10. 
07.16.10. 
A  
Yes 
IP 
368.46No
    
10 %416.70
  
7680612460206Synthetika
7738399 
Composition
irinotecani hydrochloridum trihydricum 500 mg, sorbitolum 1125 mg, acidum lacticum, acidum hydrochloridum ad pH, natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 25 ml.
Packungsbestandteile
Concentrate for infusion 
  
 
Active AgentDose
Irinotecan Hydrochloride Trihydrate500mg / 25ml
BAG: Active AgentDose
Irinotecan Hydrochloride Trihydrate500 mg
 
Inactive agentsDose
  
Lactic Acid 
  
Sorbitol1125mg / 25ml
 
Source
Data was imported : 11.07.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home